Second vote and conclusions

Date 09 October 2016
Event ESMO 2016 Congress
Session Should combined endocrine therapy with targeted agents now be the standard of care for ER+ metastatic breast cancer?
Topics Breast Cancer, Metastatic
Presenter Michael Gnant
Authors M. Gnant
  • Vienna University, Vienna/AT